Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alternative Schedule of Velcade/Dexamethasone Plus Doxil in Multiple Myeloma
NCT00366106Phase 2Terminated
- Sponsor
- Accelerated Community Oncology Research Network
- Start
- Jul 2006
- Primary completion
- Mar 2011
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in multiple myeloma (MM), sponsored by Accelerated Community Oncology Research Network. Started Jul 2006; status: terminated.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00366106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00366106.